Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Change to Scheduled Date to Commence Dividend Payments
Financial Briefing for the Second Quarter (Interim) of the Fiscal Year Ended March 31, 2026 (Fiscal 2025)
Notice Concerning Revisions to Financial Results Forecast
Supplementary Explanatory Materials on Financial Results for the Six Months Ended September 30, 2025
Consolidated Financial Results for the Six Months Ended September 30, 2025 [Japanese GAAP]
Linzagolix Approved for Marketing in Taiwan
Licensing Agreement for "Linzagolix" with Searchlight Pharma in Canada
Notice Regarding Sale of Investment Securities (Result)
Licensing Agreement with Viridian Therapeutics for "Veligrotug" and "VRDN-003" in Treatment of Thyroid Eye Disease
Consolidated Financial Results for the Three Months Ended June 30, 2025 [Japanese GAAP]
Notice Concerning Revisions to Financial Results Forecast and Recording of Extraordinary Income
Supplementary Explanatory Materials on Financial Results for the Three Months Ended June 30, 2025
Notice Regarding Completion of Disposal of Treasury Stocks as Restricted Stock for Members of the Board and Corporate Officers
New Launch of TAVALISSE for Chronic Idiopathic Thrombocytopenic Purpura Treatment in South Korea
Notice Concerning Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers
Financial Briefing for the Fiscal Year Ended March 31, 2025 (Fiscal 2024)
Notice Concerning the Results of the Acquisition of Treasury Shares, Through Off-Auction Treasury Share Repurchase Trading System
Supplementary Explanatory Materials on Financial Results for the Fiscal Year Ended March 31, 2025
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 [Japanese GAAP]
Notice Concerning Dividends of Surplus (Increase in Dividend)